A detailed history of Agate Pass Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Agate Pass Investment Management, LLC holds 3,825 shares of AMGN stock, worth $1.12 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
3,825
Previous 3,830 0.13%
Holding current value
$1.12 Million
Previous $1.2 Million 3.01%
% of portfolio
0.64%
Previous 0.65%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$309.38 - $337.38 $1,546 - $1,686
-5 Reduced 0.13%
3,825 $1.23 Million
Q2 2024

Jul 15, 2024

SELL
$262.75 - $319.31 $10,510 - $12,772
-40 Reduced 1.03%
3,830 $1.2 Million
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $10,754 - $12,982
40 Added 1.04%
3,870 $1.1 Million
Q4 2023

Jan 08, 2024

BUY
$255.7 - $288.46 $51,140 - $57,691
200 Added 5.51%
3,830 $1.1 Million
Q3 2023

Oct 13, 2023

SELL
$218.65 - $271.46 $34,546 - $42,890
-158 Reduced 4.17%
3,630 $975,000
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $47,139 - $55,741
220 Added 6.17%
3,788 $841,000
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $309,783 - $377,574
-1,372 Reduced 27.77%
3,568 $862,000
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $58,860 - $74,789
-257 Reduced 4.95%
4,940 $1.3 Million
Q3 2022

Oct 14, 2022

SELL
$224.46 - $253.15 $25,139 - $28,352
-112 Reduced 2.11%
5,197 $1.17 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $35,760 - $39,794
155 Added 3.01%
5,309 $1.29 Million
Q1 2022

Apr 28, 2022

BUY
$219.27 - $242.57 $102,179 - $113,037
466 Added 9.94%
5,154 $1.25 Million
Q4 2021

Jan 21, 2022

BUY
$198.88 - $227.6 $932,349 - $1.07 Million
4,688 New
4,688 $1.06 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Agate Pass Investment Management, LLC Portfolio

Follow Agate Pass Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agate Pass Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agate Pass Investment Management, LLC with notifications on news.